Form 4 • Statement of Changes in Beneficial Ownership
Type
Neutral
Net shares
+5,006
% of shares
100.00%
Amount (USD)
$0
Insider confidence score
90.0 out of 100
Positive
Negative
Security
Common Stock
Action
Grant
Date
2026-03-03
Code
A
Net shares
+5,006.0
Price per Share
$8.99
Amount (USD)
$45,003.94
Acquired/Disposed
Acquired
Shares Owned Before
0.0
Shares Owned After
5,006.0
1. Consists of restricted stock units granted under the company's Stock Incentive Plan. These restricted stock units vest in three annual installments beginning on the day prior to the anniversary of the date of grant, assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement.
This page is for informational purposes only. While we strive for accuracy, the summary may contain inaccuracies or omissions. Please refer to the official SEC filing for authoritative information. Open the SEC filing.